Followers

Tata Curvv final design revealed via patent image

0
Tata Curvv design patent

The Curvv SUV will be Tata Motors' first all-new model launch in 2024 and will be the brand's answer to the Hyundai Creta and Kia Seltos in India. While the Curvv SUV was shown to the general public in concept and close to production form earlier, its final design has now been revealed, thanks to a patent image that has surfaced online. 

  1. Tata Curvv to get SUV coupe-like body style
  2. Will get multiple powertrain options
  3. Curvv EV will go on sale first

Tata Curvv: What does the patent image reveal?

The patent image confirms that the Curvv SUV’s final design will be almost similar to the concept shown at last year’s Auto Expo in New Delhi. It gets a tall bumper with a wide air dam; the inserts on the air dam and grille are quite similar to the ones seen on the Harrier and Safari facelifts. The vertical headlight placement on the Curvv is also similar to these two SUVs, which will not only give it a familiar look but will also help in using common parts.

The Curvv concept’s stylish alloy wheel design also seems to be making it to the production model as seen on the patent image. The SUV will get flush door handles, which have been seen not just on the concept but also on various test mules. This feature is already seen on the Mahindra XUV700 but will be a first for Tata. At the back, the Curvv maintains its coupe-link silhouette and will be the first SUV coupe to enter the midsize SUV space in India.

Tata Curvv powertrain details

As we've reported earlier, the Curvv EV will be the first to go on sale in the coming months, with the diesel and turbo-petrol variants – in that order – launching in the second half of this year.

Tata Curvv India launch timeline

Tata Curvv EV series production will commence around April this year at Tata Motors’ Ranjangaon plant near Pune. Tata Motors has set an annual sales target of around 48,000 units for the Curvv SUV, with 12,000 units expected from the Curvv EV.



Post a Comment

0Comments
Post a Comment (0)
To Top